Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan J Little

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Nature Communications|January 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boostBo Zhang, Youyi Fong, Lauren Dang, et al.
Plos Medicine|September 22, 2023
Recommendations on data sharing in HIV drug resistance researchSeth C Inzaule, Mark J Siedner, Susan J Little, et al.
Nature Communications|March 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig A Magaret, Li Li, Allan C deCamp, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical TrialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Nature Communications|June 13, 2023
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infectionSunil K Ahuja, Muthu Saravanan Manoharan, Grace C Lee, et al.
Nature Microbiology|November 10, 2022
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Iscience|November 10, 2025
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trialAlex Luedtke, Youyi Fong, Lars van der Laan, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Nature Communications|January 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boostBo Zhang, Youyi Fong, Lauren Dang, et al.
Plos Medicine|September 22, 2023
Recommendations on data sharing in HIV drug resistance researchSeth C Inzaule, Mark J Siedner, Susan J Little, et al.
Nature Communications|March 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig A Magaret, Li Li, Allan C deCamp, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical TrialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Nature Communications|June 13, 2023
Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infectionSunil K Ahuja, Muthu Saravanan Manoharan, Grace C Lee, et al.
Nature Microbiology|November 10, 2022
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Iscience|November 10, 2025
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trialAlex Luedtke, Youyi Fong, Lars van der Laan, et al.
Nature Medicine|August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trialAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary AnalysesAngela R Branche, Nadine G Rouphael, David J Diemert, et al.
Science (New York, N.Y.)|November 6, 2010
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation, Florencia Pereyra, Xiaoming Jia, et al.
Pageof 20